Tosoh has also have moved into the health care diagnostic field. We have done so by combining our knowhow in high-performance liquid chromatography (HPLC) equipment, developed based on the special features of our packing materials, with our trace amount analysis and other technologies. Speed and accuracy have built for us a reputation as a leading manufacturer of glycohemoglobin analyzers, important tools in the long-term care of diabetic patients, who must regularly monitor their blood sugar levels.

In addition, we are developing an analyzer for certain lipoproteins that indicate patients are at high risk for arteriosclerosis.  We have, meanwhile, combined our scientific instrument analysis technology with biotechnology. This has led us to develop immunodiagnostics systems that work based on a method of measurement using monoclonal antibodies. Our customers in the clinical diagnosis field hold these systems in great regard.

We have taken several steps forward in biotechnology, particularly with the development of the transcription reverse-transcription concerted (TRC) amplification method and a system for monitoring it.  This advance has opened the door for Tosoh’s entry into genetic diagnosis, which has application in the quick and accurate diagnosis of infectious diseases.  These are just some of the ways that Tosoh R&D contributes to healthcare.